FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3024453896> ?p ?o ?g. }

• W3024453896 endingPage "e0008306" @default.
• W3024453896 startingPage "e0008306" @default.
• W3024453896 abstract "Lymphatic filariasis (LF) is endemic in Ghana, and the country has implemented the GPELF strategy since 2000 with significant progress made in the control of the disease. However, after several years of mass drug administration (MDA) implementation, there is persistent transmission in 17 of the 98 endemic districts in the country. Current approaches to surveillance are clearly unable to target untreated individuals and new strategies are required to address the endgame challenges to enhance LF elimination as a public health problem in endemic countries. Community registers are used during MDAs to enumerate community members, their age, gender, house numbers, and records of their participation in MDAs. These MDA registers represent an untapped opportunity to identify and characterize non-compliance and inform appropriate programmatic actions. In this study, we analyzed the data presented in the registers to assess the coverage and individuals' compliance in MDA.The information in the MDA registers were assessed to verify the reported coverages obtained from the district. The community registers were obtained from the district health offices and the data from each individual record was entered into a database. A simple questionnaire was used to cross-check the participation of study participants in the 2017 MDA. The questionnaire solicited data on: participation in the 2017 MDA, reasons for not taking part in the MDA, adverse events experienced, what was done for the adverse events, and willingness to participate in subsequent MDAs.We found that 40.1% of the population in the registers missed at least one MDA in 3 years (2016-2018) and the majority of them were between 10-30 years of age. The results of the questionnaire assessment indicated that 13.8% of the respondents did not receive treatment in 2017 for various reasons, the most prominent among them being absence/travel (37.1%). Data in the registers were used to verify the treatment coverage for the years 2017 and 2018, and reviewed against the reported coverage obtained from the district. Significant differences between the reported and verified coverages were only observed in four communities. However, the assessment also revealed that the reported coverage was only accurate in 33.3% of cases.The MDA registers allow for the identification of eligible individuals who were not reached during any MDA round. Thus, the MDA registers could be utilized at the community and programme levels to identify missing and untreated individuals, appropriately address their non-compliance to MDA, and thereby improve MDA coverage in each implementation unit and monitor the progress towards elimination of LF. The challenges observed through the review of the registers also offer opportunities to improve the training given to the community drug distributors." @default.
• W3024453896 created "2020-05-21" @default.
• W3024453896 creator A5000076915 @default.
• W3024453896 creator A5000970346 @default.
• W3024453896 creator A5011038636 @default.
• W3024453896 creator A5023357723 @default.
• W3024453896 creator A5041276974 @default.
• W3024453896 creator A5048646106 @default.
• W3024453896 creator A5054857534 @default.
• W3024453896 creator A5065891254 @default.
• W3024453896 creator A5087226250 @default.
• W3024453896 date "2020-05-14" @default.
• W3024453896 modified "2023-09-27" @default.
• W3024453896 title "Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges" @default.
• W3024453896 cites W1571525679 @default.
• W3024453896 cites W1634071482 @default.
• W3024453896 cites W2092922408 @default.
• W3024453896 cites W2103356588 @default.
• W3024453896 cites W2109616016 @default.
• W3024453896 cites W2126641491 @default.
• W3024453896 cites W2144580100 @default.
• W3024453896 cites W2158722434 @default.
• W3024453896 cites W2158997131 @default.
• W3024453896 cites W2235674404 @default.
• W3024453896 cites W2238272448 @default.
• W3024453896 cites W2333571867 @default.
• W3024453896 cites W2519565917 @default.
• W3024453896 cites W2566445555 @default.
• W3024453896 cites W2591878042 @default.
• W3024453896 cites W2599092454 @default.
• W3024453896 cites W2613988365 @default.
• W3024453896 cites W2759781841 @default.
• W3024453896 cites W2767328187 @default.
• W3024453896 cites W2806296929 @default.
• W3024453896 cites W2807314713 @default.
• W3024453896 cites W2892602314 @default.
• W3024453896 cites W2899911624 @default.
• W3024453896 cites W2954972289 @default.
• W3024453896 cites W2960083702 @default.
• W3024453896 cites W2994014630 @default.
• W3024453896 cites W2996716285 @default.
• W3024453896 doi "https://doi.org/10.1371/journal.pntd.0008306" @default.
• W3024453896 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7252669" @default.
• W3024453896 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32407319" @default.
• W3024453896 hasPublicationYear "2020" @default.
• W3024453896 type Work @default.
• W3024453896 sameAs 3024453896 @default.
• W3024453896 citedByCount "10" @default.
• W3024453896 countsByYear W30244538962020 @default.
• W3024453896 countsByYear W30244538962021 @default.
• W3024453896 countsByYear W30244538962022 @default.
• W3024453896 crossrefType "journal-article" @default.
• W3024453896 hasAuthorship W3024453896A5000076915 @default.
• W3024453896 hasAuthorship W3024453896A5000970346 @default.
• W3024453896 hasAuthorship W3024453896A5011038636 @default.
• W3024453896 hasAuthorship W3024453896A5023357723 @default.
• W3024453896 hasAuthorship W3024453896A5041276974 @default.
• W3024453896 hasAuthorship W3024453896A5048646106 @default.
• W3024453896 hasAuthorship W3024453896A5054857534 @default.
• W3024453896 hasAuthorship W3024453896A5065891254 @default.
• W3024453896 hasAuthorship W3024453896A5087226250 @default.
• W3024453896 hasBestOaLocation W30244538961 @default.
• W3024453896 hasConcept C126322002 @default.
• W3024453896 hasConcept C138816342 @default.
• W3024453896 hasConcept C142724271 @default.
• W3024453896 hasConcept C165901193 @default.
• W3024453896 hasConcept C197934379 @default.
• W3024453896 hasConcept C203014093 @default.
• W3024453896 hasConcept C2776158911 @default.
• W3024453896 hasConcept C2776246342 @default.
• W3024453896 hasConcept C2777629521 @default.
• W3024453896 hasConcept C2780133432 @default.
• W3024453896 hasConcept C2908647359 @default.
• W3024453896 hasConcept C512399662 @default.
• W3024453896 hasConcept C71924100 @default.
• W3024453896 hasConcept C99454951 @default.
• W3024453896 hasConceptScore W3024453896C126322002 @default.
• W3024453896 hasConceptScore W3024453896C138816342 @default.
• W3024453896 hasConceptScore W3024453896C142724271 @default.
• W3024453896 hasConceptScore W3024453896C165901193 @default.
• W3024453896 hasConceptScore W3024453896C197934379 @default.
• W3024453896 hasConceptScore W3024453896C203014093 @default.
• W3024453896 hasConceptScore W3024453896C2776158911 @default.
• W3024453896 hasConceptScore W3024453896C2776246342 @default.
• W3024453896 hasConceptScore W3024453896C2777629521 @default.
• W3024453896 hasConceptScore W3024453896C2780133432 @default.
• W3024453896 hasConceptScore W3024453896C2908647359 @default.
• W3024453896 hasConceptScore W3024453896C512399662 @default.
• W3024453896 hasConceptScore W3024453896C71924100 @default.
• W3024453896 hasConceptScore W3024453896C99454951 @default.
• W3024453896 hasIssue "5" @default.
• W3024453896 hasLocation W30244538961 @default.
• W3024453896 hasLocation W30244538962 @default.
• W3024453896 hasLocation W30244538963 @default.
• W3024453896 hasLocation W30244538964 @default.
• W3024453896 hasLocation W30244538965 @default.
• W3024453896 hasOpenAccess W3024453896 @default.
• W3024453896 hasPrimaryLocation W30244538961 @default.

• next